Pharmacovigilance guideline E2B(R3) PART-1

This presentation explains one of the pharmacovigilance guideline that describe about the electronic transmission of ICSR (Individual Case Safety Report).
This presentation explains in very detail about the changes that what they have implemented in this revision. It will be very useful for the people who are working in pharmacovigilance domain.

[@pavanreddy7885]

Great session

[@DauduzzamanShakil]

Nice sir

[@namrathanagesh8657]

Excellent.. 😊 Expecting more videos regarding pharmacovigilance and regulatory.. 😊

[@NehaDas-iz4gu]

Excellent..😊😊

[@rajatkumardebata6658]

Great good job @Shiva

[@drrajasundar]

Great job! Really appreciate it!

[@MrSandipthakor]

Very nice and clean information

[@jaggisran6753]

Clear and understandable

[@mnhyi]

It's superb.Please make more videos on this.

[@sundarraman5680]

Superb Siva....

[@VenuGopal-lg5gl]

Super sir, please add much on the granular changes in detail...
Kudos...

[@SriramYerroju]

Good job shiva 👌🏻

[@sundarraman5680]

Good

[@devenderrajuladevi1164]

Excellent.. can we expect more videos in Aggregate reporting?

[@sr-m3725]

Can you take presentation of Good pharmacovigilance practice revision 2.(Module 6)

[@rajitaravidass3307]

Do you provide training in ARISg?

[@rajatkumardebata6658]

If possible plz give a presentation on future of pv in automation

[@dubals3806]

What if difference between E2B,R2 and E2B,R3

[@sumangowda8613]

Sir can we do diploma in clinical research and pharmacovigilance or should M Pharmacy in pharmacology

[@hariomkesari1845]

Icsr compliance and submission guideline and timeline

[@rendeep101]

Super sir, please add much on the granular changes in detail...
Kudos...